Papaverine - NDC Database

7 records found
Page:1
0517-4002 Sep 01, 1995
Papaverine Hydrochloride 30 mg/ml Intravenous Injection, Solution by American Regent, Inc.
0517-4010 Sep 01, 1995
Papaverine Hydrochloride 30 mg/ml Intravenous Injection, Solution by American Regent, Inc.
14789-121 Jun 28, 2021
Papaverine Hydrochloride 30 mg/ml Intramuscular; Intravenous Injection by Nexus Pharmaceuticals Inc
54288-142 Jul 10, 2021
Papaverine Hydrochloride 30 mg/ml Parenteral Injection, Solution by Bpi Labs LLC
66758-014 Dec 01, 2008
Papaverine Hydrochloride 30 mg/ml Intramuscular; Intravenous Injection, Solution by Ebewe Parenta Pharmaceuticals Inc
66758-015 Dec 01, 2008
Papaverine Hydrochloride 30 mg/ml Intramuscular; Intravenous Injection, Solution by Ebewe Parenta Pharmaceuticals Inc
72516-024 Feb 01, 2021
Papaverine Hydrochloride 30 mg/ml Intravenous Injection, Solution by Oryza Pharmaceuticals Inc.
Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.